SMC – Scottish Pharmacist

SMC accepts three new medicines for use by NHSScotland

The Scottish Medicines Consortium (SMC) which advises on newly licensed medicines for use by NHSScotland has today (Monday 8 November) published advice acceptin... Read More...

Single tablet cholesterol-lowering combination accepted for NHS use in Scotland

• High blood cholesterol increases the risk of cardiovascular disease (CVD), which was the leading cause of death in Scotland in 2020, equating to nearly 50 pe... Read More...

SMC issues positive advice for treatment with Ofev® (nintedanib) for patients with chronic fibrosing interstitial lung diseases with a progressive phenotype (PF-ILD)

The Scottish Medicines Consortium (SMC) has today announced that Ofev® (nintedanib) has been accepted for use by NHSScotland for the treatment of adult patients... Read More...

SMC Issues Positive Decision for Treatment with AbbVie’s RINVOQ®▼(upadacitinib) in Severe Active Rheumatoid Arthritis (RA)

Positive indication means upadacitinib will be available to those with previously treated severe active RA* SMC approval is based on data from pivotal Ph... Read More...

New breast cancer medication accepted by SMC

Scottish Medicines Consortium (SMC) has accepted PROSTAP® SR DCS & PROSTAP® 3 DCS (leuprorelin acetate) to treat early and advanced breast cancer. Leupro... Read More...

SMC accepts four new medicines for use by NHSScotland

The Scottish Medicines Consortium (SMC), which advises on newly licensed medicines for use by NHSScotland, has today published advice on four new medicines. ... Read More...